Notice: This CMS-approved document has been submitted - Philips ...
Notice: This CMS-approved document has been submitted - Philips ... Notice: This CMS-approved document has been submitted - Philips ...
CMS-1403-FC Act].” According to the commenter, the physician interpretation of a diagnostic test is not a service described in section 1861(s)(3) of the Act, as physician services are described in section 1861(s)(1) of the Act. Other commenters stated that, in enacting section 1842(n) of the Act, the Congress specifically limited the applicability of the anti-markup provisions to diagnostic tests. Commenters expressed concern that applying an anti- markup payment limitation to the PC of diagnostic tests is inconsistent with the plain meaning of the law and Congressional intent. Response: As explained in the preamble to the CY 2008 PFS final rule with comment period (72 FR 66308 through 66309), despite the fact that we implemented section 1842(n)(1) of the Act to impose an anti-markup payment limitation only on the TC of diagnostic tests, we are not prevented from applying an anti-markup payment limitation to the PC of a diagnostic test. We believe that our general rulemaking authority under sections 1102(a) and 1871(a) of the Act provides us with authority to effectuate fully the Congress’s intent in enacting section 1842(n)(1) the Act to remove the profit incentive for ordering unnecessary diagnostic tests. As we indicated in the preamble to the CY 2008 PFS final rule 436
CMS-1403-FC with comment period, the profit incentive to order unnecessary diagnostic tests remains if the billing physician or other supplier may markup the PC of the test (72 FR 66315). Moreover, and as also discussed in the preamble of the CY 2008 PFS final rule with comment period, section 1842(b)(6) of the Act authorizes us, but does not command us, to allow reassignment of physician services, including the PC of a diagnostic test (72 FR 66309). At this time, we are not prohibiting reassignment of PCs and instead requiring direct billing, but we are imposing restrictions on the reassignment of PCs. That is, a PC that is reassigned by the performing physician to the billing physician or other supplier that ordered the PC may not be marked up by the billing physician or other supplier, unless the performing physician shares a practice with the billing physician or other supplier. If a physician or other supplier that orders a PC does not find that billing for the PC under an arrangement that is subject to the anti-markup provisions is profitable or financially worthwhile, that physician or other supplier is free to not accept reassignment and instead have the performing physician or other supplier bill directly for the PC. 437
- Page 385 and 386: CMS-1403-FC N. Physician Self-Refer
- Page 387 and 388: CMS-1403-FC arrangements, and the l
- Page 389 and 390: CMS-1403-FC below are related to ea
- Page 391 and 392: CMS-1403-FC clinical practice. With
- Page 393 and 394: CMS-1403-FC In the CY 2009 PFS prop
- Page 395 and 396: CMS-1403-FC would be outside the sc
- Page 397 and 398: CMS-1403-FC reflect objective quali
- Page 399 and 400: CMS-1403-FC quality resulting from
- Page 401 and 402: CMS-1403-FC payments should be reas
- Page 403 and 404: CMS-1403-FC changes in referral pat
- Page 405 and 406: CMS-1403-FC the alternative, we pro
- Page 407 and 408: CMS-1403-FC finalize this condition
- Page 409 and 410: CMS-1403-FC and “quality maintena
- Page 411 and 412: CMS-1403-FC date. We seek comments
- Page 413 and 414: CMS-1403-FC existing exceptions to
- Page 415 and 416: CMS-1403-FC our general rulemaking
- Page 417 and 418: CMS-1403-FC these approaches. We pr
- Page 419 and 420: CMS-1403-FC building in which the b
- Page 421 and 422: CMS-1403-FC were concerned that thi
- Page 423 and 424: CMS-1403-FC supplier will be subjec
- Page 425 and 426: CMS-1403-FC numerical test for the
- Page 427 and 428: CMS-1403-FC space in which the orde
- Page 429 and 430: CMS-1403-FC disadvantage nonproblem
- Page 431 and 432: CMS-1403-FC would be simpler to not
- Page 433 and 434: CMS-1403-FC IDTF standards in §410
- Page 435: CMS-1403-FC that rule, the Governme
- Page 439 and 440: CMS-1403-FC 1842(n)(1) of the Act,
- Page 441 and 442: CMS-1403-FC anti-markup provisions
- Page 443 and 444: CMS-1403-FC her group practice woul
- Page 445 and 446: CMS-1403-FC A commenter representin
- Page 447 and 448: CMS-1403-FC tenens arrangements cou
- Page 449 and 450: CMS-1403-FC other supplier. We are
- Page 451 and 452: CMS-1403-FC on pathology reports or
- Page 453 and 454: CMS-1403-FC patients. According to
- Page 455 and 456: CMS-1403-FC from sharing a practice
- Page 457 and 458: CMS-1403-FC Group A orders the TC a
- Page 459 and 460: CMS-1403-FC physicians the flexibil
- Page 461 and 462: CMS-1403-FC Response: We recognize
- Page 463 and 464: CMS-1403-FC Response: Because the d
- Page 465 and 466: CMS-1403-FC limited by the proposed
- Page 467 and 468: CMS-1403-FC Response: With respect
- Page 469 and 470: CMS-1403-FC to focus on the medical
- Page 471 and 472: CMS-1403-FC service” approach bec
- Page 473 and 474: CMS-1403-FC have the right to recei
- Page 475 and 476: CMS-1403-FC 2 approach finalized he
- Page 477 and 478: CMS-1403-FC the ordering physician
- Page 479 and 480: CMS-1403-FC ensure an adequate nexu
- Page 481 and 482: CMS-1403-FC entity” should be def
- Page 483 and 484: CMS-1403-FC between the performing
- Page 485 and 486: CMS-1403-FC supplier” to encompas
<strong>CMS</strong>-1403-FC<br />
with comment period, the profit incentive to order<br />
unnecessary diagnostic tests remains if the billing<br />
physician or other supplier may markup the PC of the test<br />
(72 FR 66315). Moreover, and as also discussed in the<br />
preamble of the CY 2008 PFS final rule with comment period,<br />
section 1842(b)(6) of the Act authorizes us, but does not<br />
command us, to allow reassignment of physician services,<br />
including the PC of a diagnostic test (72 FR 66309). At<br />
this time, we are not prohibiting reassignment of PCs and<br />
instead requiring direct billing, but we are imposing<br />
restrictions on the reassignment of PCs. That is, a PC<br />
that is reassigned by the performing physician to the<br />
billing physician or other supplier that ordered the PC may<br />
not be marked up by the billing physician or other<br />
supplier, unless the performing physician shares a practice<br />
with the billing physician or other supplier. If a<br />
physician or other supplier that orders a PC does not find<br />
that billing for the PC under an arrangement that is<br />
subject to the anti-markup provisions is profitable or<br />
financially worthwhile, that physician or other supplier is<br />
free to not accept reassignment and instead have the<br />
performing physician or other supplier bill directly for<br />
the PC.<br />
437